BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8305742)

  • 1. Interconversion and stability of duocarmycins, a new family of antitumor antibiotics: correlation to their cytotoxic and antimicrobial activities in vitro.
    Ichimura M; Ogawa T; Takahashi K; Mihara A; Takahashi I; Nakano H
    Oncol Res; 1993; 5(4-5):165-71. PubMed ID: 8305742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duocarmycins, new antitumor antibiotics produced by Streptomyces; producing organisms and improved production.
    Ichimura M; Ogawa T; Katsumata S; Takahashi K; Takahashi I; Nakano H
    J Antibiot (Tokyo); 1991 Oct; 44(10):1045-53. PubMed ID: 1955385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.
    Nagamura S; Asai A; Amishiro N; Kobayashi E; Gomi K; Saito H
    J Med Chem; 1997 Mar; 40(6):972-9. PubMed ID: 9083487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
    Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
    Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duocarmycins, potent antitumor antibiotics produced by Streptomyces sp. structures and chemistry.
    Yasuzawa T; Muroi K; Ichimura M; Takahashi I; Ogawa T; Takahashi K; Sano H; Saitoh Y
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):378-91. PubMed ID: 7774022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole analogues of duocarmycin B2.
    Nagamura S; Kobayashi E; Gomi K; Saito H
    Bioorg Med Chem; 1996 Aug; 4(8):1379-91. PubMed ID: 8879561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of AminoCBIs: highly reactive but highly cytotoxic analogues of the duocarmycins.
    Tercel M; Pruijn FB; O'Connor PD; Liyanage HD; Atwell GJ; Alix SM
    Chembiochem; 2014 Sep; 15(13):1998-2006. PubMed ID: 25087870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on duocarmycin SA and its derivatives.
    Nagamura S; Asai A; Kobayashi E; Gomi K; Saito H
    Bioorg Med Chem; 1997 Mar; 5(3):623-30. PubMed ID: 9113339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of duocarmycin derivatives.
    Nagamura S; Kanda Y; Kobayashi E; Gomi K; Saito H
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1530-5. PubMed ID: 7586077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.
    Parrish JP; Hughes TV; Hwang I; Boger DL
    J Am Chem Soc; 2004 Jan; 126(1):80-1. PubMed ID: 14709069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective treatment of cancer: synthesis, biological evaluation and structural elucidation of novel analogues of the antibiotic CC-1065 and the duocarmycins.
    Tietze LF; Major F; Schuberth I; Spiegl DA; Krewer B; Maksimenka K; Bringmann G; Magull J
    Chemistry; 2007; 13(16):4396-409. PubMed ID: 17455190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel furano analogues of duocarmycin C1 and C2: design, synthesis, and biological evaluation of seco-iso-cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues.
    Howard TT; Lingerfelt BM; Purnell BL; Scott AE; Price CA; Townes HM; McNulty L; Handl HL; Summerville K; Hudson SJ; Bowen JP; Kiakos K; Hartley JA; Lee M
    Bioorg Med Chem; 2002 Sep; 10(9):2941-52. PubMed ID: 12110316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
    Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
    J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duocarmycins--natures prodrugs?
    Searcey M
    Curr Pharm Des; 2002; 8(15):1375-89. PubMed ID: 12052214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
    Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
    J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a bromide leaving group on the properties of nitro analogs of the duocarmycins as hypoxia-activated prodrugs and phosphate pre-prodrugs for antitumor therapy.
    Stevenson RJ; Denny WA; Ashoorzadeh A; Pruijn FB; van Leeuwen WF; Tercel M
    Bioorg Med Chem; 2011 Oct; 19(20):5989-98. PubMed ID: 21920763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics.
    Gomi K; Kobayashi E; Miyoshi K; Ashizawa T; Okamoto A; Ogawa T; Katsumata S; Mihara A; Okabe M; Hirata T
    Jpn J Cancer Res; 1992 Jan; 83(1):113-20. PubMed ID: 1544867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing beta-(5',6',7'-trimethoxy-2'-indolyl)acryloyl group.
    Amishiro N; Nagamura S; Kobayashi E; Okamoto A; Gomi K; Okabe M; Saito H
    Bioorg Med Chem; 2000 Jul; 8(7):1637-43. PubMed ID: 10976511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site specific covalent alkylation of DNA by antitumor antibiotics, duocarmycin A and kapurimycin A3.
    Sugiyama H; Lam CK; Hosoda M; Saito I
    Nucleic Acids Symp Ser; 1991; (25):75-6. PubMed ID: 1842103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment A of duocarmycin B2.
    Nagamura S; Asai A; Kanda Y; Kobayashi E; Gomi K; Saito H
    Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1723-30. PubMed ID: 8855367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.